JPMorgan Chase is being sued in Manhattan federal court for allegedly charging surprise fees when it stopped allowing its customers to buy cryptocurrency with credit cards.
According to Reuters, when the company made the change in late January, it began treating the purchases as cash advances.
The suit, which was filed on Tuesday, April 10, on behalf of a proposed nationwide class, alleges that Chase charged both extra fees and much higher interest rates on the cash advances than on the credit cards. The bank also refused to refund the charges after receiving customer complaints.
The lawsuit explains that the plaintiff, Idaho resident Brady Tucker, was charged US$143.30 in fees and US$20.61 in surprise interest charges by Chase for five cryptocurrency transactions he made between January 27 and February 2.
When Tucker called Chase’s customer service line to dispute the charges, the bank refused to remove them, the suit explained. And then, with no advance warning, Chase “stuck the plaintiff with the bill, after the fact of his transactions, and insisted that he pay it.”
A lawyer for Tucker could not be reached for comment, but the lawsuit alleges that hundreds or possibly thousands of other Chase customers were hit with these surprise charges.
The lawsuit specifically accuses Chase of violating the US Truth in Lending Act, which requires credit card companies to notify their customers in writing of any significant change in charges or terms. The lawsuit is asking for actual damages and statutory damages of US$1 million.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Fires Head of Copyright Office, Throwing U.S. AI Policy Into Disarray
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
H-E-B Joins Antitrust Battle Against Teva Over MS Drug Monopoly
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece